DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 17503507.
- Also identified by PMC identifier 2823266.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
DBH is a candidate gene in Parkinson's disease (PD) and contains a putative functional polymorphism (-1021C-->T) that has been reported to modify PD susceptibility. We examined -1021C-->T in a sample of 1,244 PD patients and 1,186 unrelated control subjects. There was no significant difference in allele (p = 0.14) or genotype (p = 0.26) frequencies between the two groups. A similar result was obtained after pooling our data with those previously published. Furthermore, we found no evidence for an effect of genotype on age at onset among patients. Our findings argue against DBH -1021C-->T as a risk factor or age at onset modifier in PD.
Medical subject headings
- Dopamine beta-Hydroxylase
- Parkinson Disease
- Polymorphism, Genetic